FDA has issued warning letters to two companies for illegally selling unapproved products containing cannabidiol (CBD) in ways that violate the FD&C Act, including claims that they can treat medical conditions, including opioid addiction.
Read more: FDA Warns Companies Illegally Selling CBD Products to Treat Medical Conditions, Opioid Addiction